MEDIZEN HUMANCARE Inc. (XKON:236340)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,095.00
-50.00 (-2.33%)
At close: Jul 31, 2025, 3:30 PM KST
-2.33%
Market Cap4.61B
Revenuen/a
Net Incomen/a
Shares Out2.30M
EPSn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40
Average Volume191
Open2,010.00
Previous Close2,145.00
Day's Range2,000.00 - 2,095.00
52-Week Range1,432.00 - 4,200.00
Beta0.01
RSI40.67
Earnings Daten/a

About United States Steel

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile

News

There is no news available yet.